Literature DB >> 27139901

Vesicoureteral reflux and the extracellular matrix connection.

Fatima Tokhmafshan1, Patrick D Brophy2, Rasheed A Gbadegesin3,4, Indra R Gupta5,6.   

Abstract

Primary vesicoureteral reflux (VUR) is a common pediatric condition due to a developmental defect in the ureterovesical junction. The prevalence of VUR among individuals with connective tissue disorders, as well as the importance of the ureter and bladder wall musculature for the anti-reflux mechanism, suggest that defects in the extracellular matrix (ECM) within the ureterovesical junction may result in VUR. This review will discuss the function of the smooth muscle and its supporting ECM microenvironment with respect to VUR, and explore the association of VUR with mutations in ECM-related genes.

Entities:  

Keywords:  Collagen; Cutis laxa; Ehlers–Danlos syndrome; Elastin; Joint hypermobility; Marfan syndrome; Tenascin-XB; Ureterovesical junction; Vesicoureteral reflux; Williams syndrome

Mesh:

Year:  2016        PMID: 27139901      PMCID: PMC5376290          DOI: 10.1007/s00467-016-3386-5

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  167 in total

Review 1.  Elastic proteins: biological roles and mechanical properties.

Authors:  John Gosline; Margo Lillie; Emily Carrington; Paul Guerette; Christine Ortlepp; Ken Savage
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2002-02-28       Impact factor: 6.237

Review 2.  Joint hypermobility syndromes: the pathophysiologic role of tenascin-X gene defects.

Authors:  Manon C Zweers; Alan J Hakim; Rodney Grahame; Joost Schalkwijk
Journal:  Arthritis Rheum       Date:  2004-09

3.  Embryology and anatomy of the vesicoureteric junction with special reference to the etiology of vesicoureteral reflux.

Authors:  Christian Radmayr; Christian Schwentner; Andreas Lunacek; Anastasios Karatzas; Josef Oswald
Journal:  Ther Adv Urol       Date:  2009-12

4.  Hypermobility in two Dutch school populations.

Authors:  D G Rikken-Bultman; L Wellink; P W van Dongen
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1997-06       Impact factor: 2.435

5.  A view on the anatomy of the ureterovesical junction.

Authors:  J W Noordzij; N F Dabhoiwala
Journal:  Scand J Urol Nephrol       Date:  1993

6.  Abnormal copper metabolism and deficient lysyl oxidase activity in a heritable connective tissue disorder.

Authors:  H Kuivaniemi; L Peltonen; A Palotie; I Kaitila; K I Kivirikko
Journal:  J Clin Invest       Date:  1982-03       Impact factor: 14.808

7.  Endoscopic treatment with dextranomer-hyaluronic acid for vesicoureteral reflux: histological findings.

Authors:  A Stenberg; E Larsson; G Läckgren
Journal:  J Urol       Date:  2003-03       Impact factor: 7.450

8.  Prevalence estimation of Williams syndrome.

Authors:  Petter Strømme; Per G Bjørnstad; Kjersti Ramstad
Journal:  J Child Neurol       Date:  2002-04       Impact factor: 1.987

9.  Hypermobility: prevalence and features in a Swedish population.

Authors:  L G Larsson; J Baum; G S Mudholkar; D K Srivastava
Journal:  Br J Rheumatol       Date:  1993-02

10.  Tenascin-X induces cell detachment through p38 mitogen-activated protein kinase activation.

Authors:  Shinpei Fujie; Hiroshi Maita; Hiroyoshi Ariga; Ken-ichi Matsumoto
Journal:  Biol Pharm Bull       Date:  2009-10       Impact factor: 2.233

View more
  4 in total

Review 1.  Tenascin-X, Congenital Adrenal Hyperplasia, and the CAH-X Syndrome.

Authors:  Walter L Miller; Deborah P Merke
Journal:  Horm Res Paediatr       Date:  2018-05-07       Impact factor: 2.852

2.  Congenital Anomalies of the Kidney and Urinary Tract: A Clinical Review.

Authors:  Emily Stonebrook; Monica Hoff; John David Spencer
Journal:  Curr Treat Options Pediatr       Date:  2019-06-11

Review 3.  Physiopathology of vesico-ureteral reflux.

Authors:  Salvatore Arena; Roberta Iacona; Pietro Impellizzeri; Tiziana Russo; Lucia Marseglia; Eloisa Gitto; Carmelo Romeo
Journal:  Ital J Pediatr       Date:  2016-11-29       Impact factor: 2.638

4.  Tenascin-X-Discovery and Early Research.

Authors:  Walter L Miller
Journal:  Front Immunol       Date:  2021-01-11       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.